Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis

This research describes the exploration of a new scaffold with the potential to be developed in to a new drug for the treatment of Human African Trypanosomiasis (HAT), a neglected disease endemic in sub-Saharan Africa. Derivatives of an isoquinoline scaffold were synthesised and evaluated for their...

Full description

Bibliographic Details
Main Author: Cullen, Danica Renae
Format: Thesis
Published: Curtin University 2016
Online Access:http://hdl.handle.net/20.500.11937/52988
_version_ 1848759052889227264
author Cullen, Danica Renae
author_facet Cullen, Danica Renae
author_sort Cullen, Danica Renae
building Curtin Institutional Repository
collection Online Access
description This research describes the exploration of a new scaffold with the potential to be developed in to a new drug for the treatment of Human African Trypanosomiasis (HAT), a neglected disease endemic in sub-Saharan Africa. Derivatives of an isoquinoline scaffold were synthesised and evaluated for their in vitro activity against T.b.rhodesiense, the causative agent of HAT. Five derivatives were identified with inhibition of T.b.rhodesiense in the sub-micromolar range with good selectivity over mammalian cells.
first_indexed 2025-11-14T09:53:45Z
format Thesis
id curtin-20.500.11937-52988
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:53:45Z
publishDate 2016
publisher Curtin University
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-529882018-06-20T04:59:48Z Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis Cullen, Danica Renae This research describes the exploration of a new scaffold with the potential to be developed in to a new drug for the treatment of Human African Trypanosomiasis (HAT), a neglected disease endemic in sub-Saharan Africa. Derivatives of an isoquinoline scaffold were synthesised and evaluated for their in vitro activity against T.b.rhodesiense, the causative agent of HAT. Five derivatives were identified with inhibition of T.b.rhodesiense in the sub-micromolar range with good selectivity over mammalian cells. 2016 Thesis http://hdl.handle.net/20.500.11937/52988 Curtin University fulltext
spellingShingle Cullen, Danica Renae
Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis
title Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis
title_full Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis
title_fullStr Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis
title_full_unstemmed Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis
title_short Development of tetrahydroisoquinoline analogues: Towards a treatment for Human African Trypanosomiasis
title_sort development of tetrahydroisoquinoline analogues: towards a treatment for human african trypanosomiasis
url http://hdl.handle.net/20.500.11937/52988